Company Info
| Phone: | (408) 777-1417 |
| Year Established: | 1998 |
| Ticker: | DRRX |
| Exchange: | NASDAQ |
Contacts
| Primary: | Keith Lui VP, Business Development |
| Other: | James E. Brown, DMV President & CEO Timothy M. Papp CFO Norman L. Sussman, M.D., FAASLD CMO WeiQi Lin, M.D., Ph.D. Executive VP, R&D Steve Helmer Chief Patent Counsel |
Company Description
DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program.
